ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Top Neurology Prescribers in North Carolina

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
JAMES SOWELL MD

Neurology

14,773

$1.16M

807
354 are 65+

1%
patients receiving schedule two controlled substances

Avg: 5%

3%
patients receiving schedule three controlled substances

Avg: 3%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

21%
prescriptions for brand name drugs

Avg: 25%

$78
Average prescription price

Avg: $230

ELAINE FERARU MD

Neurology

8,672

$1.26M

484
211 are 65+

49%
patients receiving schedule two controlled substances

Avg: 5%

27%
patients receiving schedule three controlled substances

Avg: 3%

8%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

19%
prescriptions for brand name drugs

Avg: 25%

$145
Average prescription price

Avg: $230

EDWARD HILL M.D.

Neurology

8,200

$2.39M

905
541 are 65+

8%
patients receiving schedule two controlled substances

Avg: 5%

9%
patients receiving schedule three controlled substances

Avg: 3%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

30%
prescriptions for brand name drugs

Avg: 25%

$292
Average prescription price

Avg: $230

JAMES PATTON MD

Neurology

7,650

$1.99M

844
501 are 65+

4%
patients receiving schedule two controlled substances

Avg: 5%

8%
patients receiving schedule three controlled substances

Avg: 3%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

19%
prescriptions for brand name drugs

Avg: 25%

$261
Average prescription price

Avg: $230

ANDREAS RUNHEIM M.D.

Neurology

7,500

$1.77M

812
497 are 65+

9%
patients receiving schedule two controlled substances

Avg: 5%

18%
patients receiving schedule three controlled substances

Avg: 3%

6%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

21%
prescriptions for brand name drugs

Avg: 25%

$235
Average prescription price

Avg: $230

BRUCE SOLOMON D.O.

Neurology

7,173

$1.28M

708
465 are 65+

13%
patients receiving schedule two controlled substances

Avg: 5%

7%
patients receiving schedule three controlled substances

Avg: 3%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

27%
prescriptions for brand name drugs

Avg: 25%

$178
Average prescription price

Avg: $230

MOHAMMAD BOLOURI MD

Neurology

6,465

$764K

715
678 are 65+

0%
patients receiving schedule two controlled substances

Avg: 5%

0%
patients receiving schedule three controlled substances

Avg: 3%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

38%
prescriptions for brand name drugs

Avg: 25%

$118
Average prescription price

Avg: $230

JAMES LOVE M.D.

Neurology

6,363

$1.48M

649
516 are 65+

5%
patients receiving schedule two controlled substances

Avg: 5%

2%
patients receiving schedule three controlled substances

Avg: 3%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

26%
prescriptions for brand name drugs

Avg: 25%

$232
Average prescription price

Avg: $230

JOSEPH MILLER MD

Neurology

5,934

$597K

592
390 are 65+

6%
patients receiving schedule two controlled substances

Avg: 5%

8%
patients receiving schedule three controlled substances

Avg: 3%

5%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

18%
prescriptions for brand name drugs

Avg: 25%

$101
Average prescription price

Avg: $230

CHARLES WILLIS M.D.

Neurology

5,577

$1.3M

570
374 are 65+

6%
patients receiving schedule two controlled substances

Avg: 5%

5%
patients receiving schedule three controlled substances

Avg: 3%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

24%
prescriptions for brand name drugs

Avg: 25%

$233
Average prescription price

Avg: $230

CRAIG DUBOIS M.D.

Neurology

5,485

$678K

493
277 are 65+

11%
patients receiving schedule two controlled substances

Avg: 5%

10%
patients receiving schedule three controlled substances

Avg: 3%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

22%
prescriptions for brand name drugs

Avg: 25%

$124
Average prescription price

Avg: $230

DAVID MEYER MD

Neurology

5,045

$2.24M

498
337 are 65+

0%
patients receiving schedule two controlled substances

Avg: 5%

6%
patients receiving schedule three controlled substances

Avg: 3%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

36%
prescriptions for brand name drugs

Avg: 25%

$444
Average prescription price

Avg: $230

CHRISTOPHER CONNELLY MD

Neurology

5,018

$656K

432
266 are 65+

7%
patients receiving schedule two controlled substances

Avg: 5%

5%
patients receiving schedule three controlled substances

Avg: 3%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

23%
prescriptions for brand name drugs

Avg: 25%

$131
Average prescription price

Avg: $230

THOR BORRESEN MD

Neurology

4,897

$1.49M

360
224 are 65+

9%
patients receiving schedule two controlled substances

Avg: 5%

13%
patients receiving schedule three controlled substances

Avg: 3%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

23%
prescriptions for brand name drugs

Avg: 25%

$304
Average prescription price

Avg: $230

SUZANNE MCADAMS M.D.

Neurology

4,825

$1.39M

399
250 are 65+

5%
patients receiving schedule two controlled substances

Avg: 5%

5%
patients receiving schedule three controlled substances

Avg: 3%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

28%
prescriptions for brand name drugs

Avg: 25%

$289
Average prescription price

Avg: $230

RICHARD SATER MD

Neurology

4,761

$1.52M

336
182 are 65+

24%
patients receiving schedule two controlled substances

Avg: 5%

28%
patients receiving schedule three controlled substances

Avg: 3%

6%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

21%
prescriptions for brand name drugs

Avg: 25%

$320
Average prescription price

Avg: $230

BING LIU MD

Neurology

4,581

$861K

527
351 are 65+

6%
patients receiving schedule two controlled substances

Avg: 5%

6%
patients receiving schedule three controlled substances

Avg: 3%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

21%
prescriptions for brand name drugs

Avg: 25%

$188
Average prescription price

Avg: $230

JOHN MALONE M.D.

Neurology

4,528

$769K

446
247 are 65+

4%
patients receiving schedule two controlled substances

Avg: 5%

12%
patients receiving schedule three controlled substances

Avg: 3%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

24%
prescriptions for brand name drugs

Avg: 25%

$170
Average prescription price

Avg: $230

ANDREA DIEDRICH MD

Neurology

4,438

$788K

422
297 are 65+

0%
patients receiving schedule two controlled substances

Avg: 5%

7%
patients receiving schedule three controlled substances

Avg: 3%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

23%
prescriptions for brand name drugs

Avg: 25%

$178
Average prescription price

Avg: $230

DOUGLAS JEFFERY MD

Neurology

4,394

$2.74M

266
58 are 65+

30%
patients receiving schedule two controlled substances

Avg: 5%

23%
patients receiving schedule three controlled substances

Avg: 3%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

28%
prescriptions for brand name drugs

Avg: 25%

$625
Average prescription price

Avg: $230

GREGORY MIEDEN MD

Neurology

4,291

$619K

399
196 are 65+

14%
patients receiving schedule two controlled substances

Avg: 5%

17%
patients receiving schedule three controlled substances

Avg: 3%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

22%
prescriptions for brand name drugs

Avg: 25%

$144
Average prescription price

Avg: $230

ANN BREWER M.D.

Neurology

4,231

$340K

167
88 are 65+

0%
patients receiving schedule two controlled substances

Avg: 5%

0%
patients receiving schedule three controlled substances

Avg: 3%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

30%
prescriptions for brand name drugs

Avg: 25%

$80
Average prescription price

Avg: $230

MOHAN DEOCHAND MD

Neurology

4,173

$497K

380
201 are 65+

19%
patients receiving schedule two controlled substances

Avg: 5%

17%
patients receiving schedule three controlled substances

Avg: 3%

6%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

15%
prescriptions for brand name drugs

Avg: 25%

$119
Average prescription price

Avg: $230

JONATHAN RICHMAN MD

Neurology

4,168

$652K

386
219 are 65+

19%
patients receiving schedule two controlled substances

Avg: 5%

12%
patients receiving schedule three controlled substances

Avg: 3%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

28%
prescriptions for brand name drugs

Avg: 25%

$156
Average prescription price

Avg: $230

ROBERT ARMSTRONG MD

Neurology

4,165

$1.3M

494
188 are 65+

6%
patients receiving schedule two controlled substances

Avg: 5%

6%
patients receiving schedule three controlled substances

Avg: 3%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

30%
prescriptions for brand name drugs

Avg: 25%

$311
Average prescription price

Avg: $230

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank